Recent Quarter Total Invested
$396,661
-$814,592.00
Recent Quarter Institutional Ownership Percentage
9.04%
-$7.42
Total Invested of Last Quarter
$1.21 M
Ownership Percentage of Last Quarter
16.46%
Cyclacel Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2023 | 363,367 | $124,000 | 0.00% | 2.89% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2023 | 230,000 | $81,581 | 0.00% | 1.83% |
| RENAISSANCE TECHNOLOGIES LLC | 11/14/2023 | 185,500 | $66,000 | 8.67% | 1.48% |
| VANGUARD GROUP INC | 12/18/2023 | 86,949 | $30,841 | 0.00% | 0.69% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/13/2023 | 86,425 | $29,989 | 40.17% | 0.69% |
| CITADEL ADVISORS LLC | 11/14/2023 | 30,745 | $10,669 | 165.32% | 0.24% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2023 | 28,759 | $9,979 | -43.73% | 0.23% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2023 | 28,400 | $10,073 | -95.73% | 0.23% |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 10/24/2023 | 20,806 | $7,380 | 0.00% | 0.17% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2023 | 16,424 | $5,826 | -8.80% | 0.13% |
| NORTHERN TRUST CORP | 11/13/2023 | 14,957 | $5,305 | 0.00% | 0.12% |
| MCILRATH & ECK, LLC | 11/16/2023 | 12,500 | $4,434 | 25.00% | 0.10% |
| STATE STREET CORP | 11/14/2023 | 10,510 | $3,647 | 0.00% | 0.08% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2023 | 9,150 | $3,242 | -30.15% | 0.07% |
| BLACKROCK INC. | 11/13/2023 | 4,697 | $1,666 | 0.00% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2023 | 3,591 | $1,275 | -0.39% | 0.03% |
| MORGAN STANLEY | 11/15/2023 | 1,200 | $426 | 0.00% | 0.01% |
| WELLS FARGO & COMPANY/MN | 11/13/2023 | 580 | $205 | 0.17% | 0.00% |
| SIGNATUREFD, LLC | 11/03/2023 | 300 | $106 | 0.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/13/2023 | 50 | $17 | 100.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2023 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2023 | 0 | $0 | -100.00% | 0.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2023 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 11/09/2023 | 0 | $0 | -100.00% | 0.00% |
Cyclacel Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CYCC shares?
During the previous two years, 1 institutional investors and hedge funds held shares of Cyclacel Pharmaceuticals, Inc.. The most heavily invested institutionals were:
NEXT Financial Group, Inc: 23,852
-
What percentage of Cyclacel Pharmaceuticals, Inc. stock is owned by institutional investors?
9.04% of Cyclacel Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CYCC ?
Institutional investors have bought a total of 23,852 shares in the last 24 months. This purchase volume represents approximately $21,705 in transactions.